Manisha Garg, MD
Endocrinology, Diabetes & Metabolism · Montgomery, ALNPI 1215215389
Payments from drug & device makers
Across 462 payments — averaging $17.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$1K
- Novo Nordisk$1K
- Abbott$760
- Dexcom, Inc.$503
- Mannkind Corporation$433
- Boehringer Ingelheim$410
- plus $4K from 31 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 89 | $1,405 |
| Novo Nordisk | 61 | $1,129 |
| Abbott | 51 | $760 |
| Dexcom, Inc. | 36 | $503 |
| Mannkind Corporation | 19 | $433 |
| Boehringer Ingelheim | 26 | $410 |
| Xeris Pharmaceuticals, Inc. | 18 | $379 |
| Sanofi-aventis U.S. LLC | 18 | $350 |
| Tandem Diabetes Care, Inc. | 12 | $281 |
| AstraZeneca(2 entities) | 15 | $258 |
| AbbVie | 13 | $240 |
| Medtronic(2 entities) | 10 | $226 |
| Amgen(2 entities) | 11 | $187 |
| BETA Bionics, Inc. | 10 | $182 |
| Corcept Therapeutics | 10 | $180 |
| Amneal Pharmaceuticals LLC | 9 | $143 |
| Kyowa Kirin, Inc. | 5 | $101 |
| IBSA Pharma Inc. | 5 | $101 |
| Radius Health, Inc. | 3 | $98 |
| Intuitive Surgical | 1 | $92 |
| Insulet Corporation | 5 | $92 |
| Amarin Pharma, Inc. | 5 | $92 |
| Bayer | 2 | $86 |
| Novartis | 5 | $78 |
| Ascendis Pharma Endocrinology Inc | 3 | $67 |
| Antares Pharma, Inc. | 3 | $61 |
| Kowa Pharmaceuticals America, Inc. | 4 | $51 |
| Pfizer | 3 | $46 |
| Ultragenyx Pharmaceutical Inc. | 1 | $30 |
| Merck | 2 | $27 |
| Amryt Pharma Holdings Ltd | 1 | $25 |
| Recordati_rare_diseases_inc. | 1 | $24 |
| Sequel Med Tech, LLC | 1 | $23 |
| Rhythm Pharmaceuticals, Inc. | 1 | $21 |
| Lifescan, Inc. | 1 | $17 |
| Johnson & Johnson | 1 | $14 |
| Companion Medical, Inc. | 1 | $13 |
How this compares
$8,222 in reported general payments places this provider in the 50th percentile of 79 endocrinology, diabetes & metabolism providers in Alabama.
See all endocrinology, diabetes & metabolism providers in Alabama →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other endocrinology, diabetes & metabolism in Montgomery
- Hima AmmanaMontgomery$9K
- Warda NiazMontgomery$8K
- Vaishall ThudiMontgomery$8K
- Elaina AdderleyMontgomery$7K
- Ahsan FarooqMontgomery$4K
- Mohammad-Ehsan OwrangiMontgomery$3K
- William GarveyBirmingham$3.8M
- Neil SchaffnerOpelika$642K
- Fernando OvalleBirmingham$516K
- Ralph TeagueBirmingham$487K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.